Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Mar;57(3):661–663. doi: 10.1128/iai.57.3.661-663.1989

Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients.

E L Hewlett 1, J L Cowell 1
PMCID: PMC313157  PMID: 2537253

Full text

PDF
661

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Au-Jensen M., Heron I. Is the acute encephalopathy test in mice suited for control of pertussis vaccines? Dev Biol Stand. 1985;61:447–451. [PubMed] [Google Scholar]
  2. BERG J. M. Neurological complications of pertussis immunization. Br Med J. 1958 Jul 5;2(5087):24–27. doi: 10.1136/bmj.2.5087.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cherry J. D. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984 Feb;14(2):1–78. doi: 10.1016/0045-9380(84)90016-1. [DOI] [PubMed] [Google Scholar]
  4. Cody C. L., Baraff L. J., Cherry J. D., Marcy S. M., Manclark C. R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981 Nov;68(5):650–660. [PubMed] [Google Scholar]
  5. Corsellis J. A., Janota I., Marshall A. K. Immunization against whooping cough: a neuropathological review. Neuropathol Appl Neurobiol. 1983 Jul-Aug;9(4):261–270. doi: 10.1111/j.1365-2990.1983.tb00113.x. [DOI] [PubMed] [Google Scholar]
  6. Joó I. Benefit versus risk factors in cholera and typhoid immunization. Dev Biol Stand. 1979;43:47–52. [PubMed] [Google Scholar]
  7. Kulenkampff M., Schwartzman J. S., Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child. 1974 Jan;49(1):46–49. doi: 10.1136/adc.49.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kurose H., Katada T., Amano T., Ui M. Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells. J Biol Chem. 1983 Apr 25;258(8):4870–4875. [PubMed] [Google Scholar]
  9. Miller D., Wadsworth J., Diamond J., Ross E. Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev Biol Stand. 1985;61:389–394. [PubMed] [Google Scholar]
  10. Munoz J. J., Peacock M. G., Hadlow W. J. Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin). Infect Immun. 1987 Apr;55(4):1004–1008. doi: 10.1128/iai.55.4.1004-1008.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pittman M. Neurotoxicity of Bordetella pertussis. Neurotoxicology. 1986 Summer;7(2):53–67. [PubMed] [Google Scholar]
  12. Pittman M. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis. 1979 May-Jun;1(3):401–412. doi: 10.1093/clinids/1.3.401. [DOI] [PubMed] [Google Scholar]
  13. Redhead K., Robinson A., Ashworth L. A., Melville-Smith M. The activity of purified Bordetella pertussis components in murine encephalopathy. J Biol Stand. 1987 Oct;15(4):341–351. doi: 10.1016/s0092-1157(87)80007-0. [DOI] [PubMed] [Google Scholar]
  14. Riley R. L., Wilson L. D., Germain R. N., Benjamin D. C. Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin. J Immunol. 1982 Oct;129(4):1553–1558. [PubMed] [Google Scholar]
  15. Ross E., Miller D. Risk and pertussis vaccine. Arch Dis Child. 1986 Jan;61(1):98–99. doi: 10.1136/adc.61.1.98-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Steinman L., Sriram S., Adelman N. E., Zamvil S., McDevitt H. O., Urich H. Murine model for pertussis vaccine encephalopathy: linkage to H-2. Nature. 1982 Oct 21;299(5885):738–740. doi: 10.1038/299738a0. [DOI] [PubMed] [Google Scholar]
  17. Steinman L., Weiss A., Adelman N., Lim M., Oehlert J., Zuniga R., Hewlett E., Falkow S. Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin. Dev Biol Stand. 1985;61:439–446. [PubMed] [Google Scholar]
  18. Steinman L., Weiss A., Adelman N., Lim M., Zuniga R., Oehlert J., Hewlett E., Falkow S. Pertussis toxin is required for pertussis vaccine encephalopathy. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8733–8736. doi: 10.1073/pnas.82.24.8733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Toyota T., Kai Y., Kakizaki M., Sakai A., Goto Y., Yajima M., Ui M. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies). Tohoku J Exp Med. 1980 Feb;130(2):105–116. doi: 10.1620/tjem.130.105. [DOI] [PubMed] [Google Scholar]
  20. Weiss A. A., Hewlett E. L. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. doi: 10.1146/annurev.mi.40.100186.003305. [DOI] [PubMed] [Google Scholar]
  21. Wiedmeier S. E., Chung H. T., Cho B. H., Kim U. H., Daynes R. A. Murine responses to immunization with pertussis toxin and bovine serum albumin: I. Mortality observed after bovine albumin challenge is due to an anaphylactic reaction. Pediatr Res. 1987 Sep;22(3):262–267. doi: 10.1203/00006450-198709000-00005. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES